Cargando…
Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors
Tumor angiogenesis is a key factor in the progression of thymic epithelial tumors (TETs). Activin A, a member of the TGFβ family, and its antagonist Follistatin are involved in several human malignancies and angiogenesis. We investigated Activin A and Follistatin in serum and tumor tissue of patient...
Autores principales: | Janik, Stefan, Bekos, Christine, Hacker, Philipp, Raunegger, Thomas, Schiefer, Ana-Iris, Müllauer, Leonhard, Veraar, Cecilia, Dome, Balazs, Klepetko, Walter, Ankersmit, Hendrik Jan, Moser, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874542/ https://www.ncbi.nlm.nih.gov/pubmed/31757999 http://dx.doi.org/10.1038/s41598-019-53671-8 |
Ejemplares similares
-
Clinical prognostic scores for patients with thymic epithelial tumors
por: Veraar, Cecilia, et al.
Publicado: (2019) -
Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis
por: Thanner, Jürgen, et al.
Publicado: (2020) -
Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis
por: Janik, Stefan, et al.
Publicado: (2017) -
Prognostic and diagnostic impact of fibrinogen, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on thymic epithelial tumors outcome
por: Janik, Stefan, et al.
Publicado: (2018) -
Expression of RAGE and HMGB1 in Thymic Epithelial Tumors, Thymic Hyperplasia and Regular Thymic Morphology
por: Moser, Bernhard, et al.
Publicado: (2014)